Get Permission Dastikop, Kiran, Kamoji, Rohith, Gurudev, Sanagoudar, and Oswal: A study of cutaneous adverse drug reactions among HIV infected adults in a tertiary care centre in north Karnataka


Introduction

With an increase in the number of drugs, adverse drug reactions have become very common in recent times. Among them cutaneous reactions have been steadily gaining importance and constitute a major proportion of all the adverse drug reactions. Innumerable epidemiological and clinical studies have highlighted the various aspects of this disorder. A large amount of data on cutaneous adverse drug reactions is being constantly updated. The early detection and treatment of cutaneous adverse drug reactions and identification of the causative agent are essential to prevent the progression of the reaction and preventing additional exposures.1

The severity of such reactions ranges from mild to severe ones. Poly pharmacy can lead to drug interactions and thereby increase the rate of ADRs.1 Iatrogenic factors that lead to adverse drug reactions include inappropriate dosage, immune dysregulation and altered metabolism in HIV patients,2, 3 inappropriate combinations of drugs and use of drugs not recommended for a particular age group.

Skin diseases including adverse reactions to drugs are thought to be more common among patients with human immunodeficiency virus infection than among other persons.4 Though the introduction of highly active antiretroviral therapy has led to significant reduction in AIDS related morbidity and mortality, the side effects and drug reactions due to such drugs are increasing. The causative drug in such adverse reactions need not be always ART, other drugs used in such individuals like ATT, drugs used to treat opportunistic infections or self medications can also cause reactions. The severity of such reactions ranges from mild to severe ones.5

   Different types of CADRs are morbilliform eruptions, fixed drug eruptions, phototoxicity, urticaria, exfoliative dermatitis, erythema multiforme, DRESS, Steven Johnson syndrome and toxic epidermal necrolysis. These reactions are commonly accompanied with derangement in laboratory parameters which may alter the course of the illness.

There are many studies regarding CADRs in HIV individuals due to ART but scanty for other drugs in general. So, this study was conducted to know the epidemiology, clinical pattern, associated laboratory parameter derangements in cutaneous adverse drug reactions in HIV individuals in our set up.

Materials and Methods

This observational study was conducted in a tertiary care centre after obtaining institutional ethical committee clearance. Total numbers of patients included was 110. All adult HIV patients with suspected cutaneous adverse reaction to any drug attending Belagavi Institute of Medical Sciences, Belagavi India were recruited after obtaining informed written consent. Detailed history regarding epidemiological data, HIV status, offending drug and any significant past history were elicited. Systemic examination and mucocutaneous examination was done in detail and the pattern of CADR was noted. Severity of the cutaneous adverse drug reaction was graded according to modified Hartwig and Siegels scoring system as mild, moderate and severe reaction.6 Causality assessment was done using Naranjo causality scale as definite, probable or possible.7 Necessary investigations like CBC, RFT, LFT, RBS, peripheral smear, serum electrolytes, urine examinations were carried out. The results obtained were studied using statistical analytic methods.

Results

Statistical analysis

Data was entered into Microsoft excel data sheet and was analyzed using SPSS 22 version software. Categorical data was represented in the form of Frequencies and proportions. Chi-square test was used as test of significance for qualitative data. Continuous data was represented as mean and SD.

Graphical representation of data

MS Excel and MS word was used to obtain various types of graphs such as bar diagram and Pie diagram.

p value (Probability that the result is true) of <0.05 was considered as statistically significant after assuming all the rules of statistical tests.

Statistical software

MS Excel, SPSS version 22 (IBM SPSS Statistics, Somers NY, USA) was used to analyze data.

Total no of patients included in the study was 110. Age distribution of the patients is shown in Table 1. Most common age group affected was 31 to 40 years (40.9%). Out of 110 patients, 54.5% were females and 45.5% were males (M: F=0.8:1) and 86.4% were married and 13.6% were unmarried.

Occupation distribution of patients in the study is as follows. Most of the patients were labourers (28.18%) followed by farmers (25.45%) and other occupation. Majority of the patients belonged to lower middle socioeconomic status (47.3%) followed by upper lower class (27.3%), upper middle class (19.1%) and lower class (6.4%) according to modified Kuppuswamy classification.

Among females, mean CD4 count was 379.38 ± 246.84 cells/mm3 and among males 332.32 ± 261.17 cells/mm3. There was no significant association between gender and CD4 count (Table 2).

Majority of the patients presented with maculopapular eruption (39.09%) (Figure 1, Figure 2, Figure 3) followed by FDE (11.8%) (Figure 4, Figure 5), angioedema (10.9%), DRESS (10%) (Figure 6), SJS (7.27%), urticaria (6.4%), pruritis (6.4%), EM (4.5%) (Figure 7), acneiform eruption (3.6%) (Figure 8), photoallergic reaction (2.72%), papular eruption (1.8%), vasculitis (1.8%) (Figure 9) and TEN (0.9%) (Figure 10). Of the 110 patients, 18 patients had >1 cutaneous presentation (Table 3).

Out of 110 cases, 40.9% of the CADRs were due to ART, 20.9% due to antibiotics, 8.2% due to NSAIDs, 2.7% due to antiepileptics, 1.8% due to ATT, 0.9% due to Herbal medicines and 24.5% due to unknown drugs (Table 4).

The most common route of administration of the culprit drug was oral (95.5%) followed by intramuscular route (3.6%). According to Naranjo scoring system, 57.27% patients had probable causality, 40% had possible causality and 2.72% had definite causality. Majority of the patients (72.7%) had mild reaction, followed by moderate (25.5%) and severe reaction (1.8%) according to modified Hartwig and Siegels system.

Most common laboratory derangement seen was increase in liver enzymes (SGOT increased in 24.5%, SGPT increased in 21.8%) followed by eosinophilia (19.1%), increased bilirubin and serum creatinine (5.5% each) (Table 5).

Mean CD4 count and cutaneous ADR is shown in Table 6.

Among SJS patients, 62.5% had increased liver enzymes, 12.5% had increased ALP, bilirubin, eosinophils, TLC, ESR and 37.5% had increased serum creatinine which shows there was a significant association between increased liver enzymes and raised Serum creatinine with SJS (Table 7).

Among patients with DRESS, SGOT was raised in 100%, SGPT raised in 81.8%, total bilirubin raised in 36.4%, eosinophilia in 90.9% and raised serum creatinine in 18.2%. This shows that there was a significant association between increased liver enzymes, total bilirubin, Eosinophilia and raised serum creatinine with DRESS (Table 8).

We had a single case of TEN with raised liver enzymes, serum creatinine and serum potassium levels with low sodium.

There was no significant association between deranged laboratory parameters with maculopapular eruption, EM, urticaria, angioedema, FDE, acneiform eruption, pruritis, vasculitis, lichenoid and photosensitive drug rash.

Table 1

Age distribution of patients

Age

No of patients

%

18-20 years

7

6.4%

21 to 30 years

18

16.4%

31 to 40 years

45

40.9%

41 to 50 years

23

20.9%

51 to 60 years

15

13.6%

>60 years

2

1.8%

Total

110

100.0%

Table 2

CD4 count and Sex distribution

Sex

CD4 Count

P value

Mean

SD

Median

Female

379.38

246.84

331.50

0.338

Male

332.32

261.17

299.50

Table 3

Cutaneous adverse drug reactions (CADRs) among patients

Clinical presentation

No of patients

%

Maculopapular eruption

43

39.09%

FDE

13

11.8%

Angioedema

12

10.9%

DRESS

11

10.0%

SJS

8

7.27%

Urticaria

7

6.4%

Pruritis

7

6.4%

EM

5

4.5%

Acneiform eruption

4

3.6%

Lichenoid eruption

3

2.7%

Photo allergic reaction

3

2.72%

Vasculitis

2

1.8%

Papular eruption

2

1.8%

TEN

1

0.9%

Table 4

Causative drug group distribution among patients

Drug Group

No of patients

%

Antibiotics

23

20.9%

ART

45

40.9%

NSAIDS

9

8.2%

Antiepileptic

3

2.7%

ATT

2

1.8%

Herbal medication

1

0.9%

Unknown

27

24.5%

Total

110

100.0%

Table 5

Deranged laboratory parameters among patients

Deranged laboratory parameters

Total patients

Percentage

SGOT increased

27

24.5%

SGPT increased

24

21.8%

ALP increased

6

5.5%

Low Protein

8

7.3%

Total bilirubin increased

6

5.5%

Eosinophilia

21

19.1%

TLC increased

6

5.5%

Hb decreased

16

14.5%

ESR increased

3

2.7%

HbS Ag positivity

1

0.9%

Serum Electrolytes abnormality (Na+low ,K+ high)

1

0.9%

Urine abnormality

3

2.7%

Serum creatinine raised

6

5.5%

Table 6

Mean CD4 count and cutaneous ADRs.

Cutaneous ADRs

Mean CD4 count(cells/mm3)

Maculopapular rash

422.66

TEN

369

EM

453

Acneiform eruption

253

SJS

331.87

Lichenoid eruption

570.33

DRESS

297.09

Angioedema

422.72

Urticaria

381.85

Papular eruption

361.5

Vasculitis

563.5

FDE

271.30

Photoallergic reaction

293

Table 7

Deranged laboratory parameters in SJS

Deranged laboratory parameters

SJS

P value

Yes

No

No of patients

%

No of patients

%

SGOT increased

5

62.5%

22

21.8%

0.024*

SGPT increased

5

62.5%

19

18.8%

0.011*

ALP increased

1

12.5%

5

5.0%

0.435

Protein Low

0

0.0%

8

7.9%

0.381

Total bilirubin increased

1

12.5%

5

5.0%

0.435

Eosinophilia

1

12.5%

20

19.8%

0.525

TLC increased

1

12.5%

5

5.0%

0.435

Hb decreased

2

25%

14

13.9%

0.495

ESR increased

1

12.5%

2

2.0%

0.107

Serum Electrolytes abnormality

0

0.0%

1

1.0%

0.764

Urine abnormality

0

0.0%

3

3.0%

0.600

Serum Creatinine increased

3

37.5%

3

3.0%

<0.001*

Table 8

Deranged laboratory parameters in DRESS

Deranged laboratory parameters

DRESS

P value

Yes

No

No of patients

%

No of patients

%

SGOT increased

11

100.0%

16

16.2%

<0.001*

SGPT increased

9

81.8%

15

15.2%

<0.001*

ALP increased

1

9.1%

5

5.1%

0.576

Low Proteins

0

0.0%

8

8.1%

0.328

Total bilirubin increased

4

36.4%

2

2.0%

<0.001*

Eosinophilia

10

90.9%

11

11.1%

<0.001*

TLC increased

1

9.1%

5

5.1%

0.576

Hb decreased

2

18.2%

14

14.1%

0.718

ESR increased

2

18.2%

1

1.0%

0.001*

Serum Electrolytes

0

0.0%

1

1.0%

0.738

Urine abnormality

0

0.0%

3

3.0%

0.558

Serum creatinine raised

2

18.2%

4

4.0%

0.05*

Figure 1

Nevirapine induced maculopapular rash

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage1.png
Figure 2

Maculopapular rash due to Efavirenz

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage2.png
Figure 3

Maculopapular rash due to Efavirenz

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage3.png
Figure 4

Fixed drug eruption due to Ofloxacin

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage4.png
Figure 5

Fixed drug eruption with oral involvement due to Metronidazole

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage5.png
Figure 6

DRESS due to Phenobarbitone

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage6.png
Figure 7

erythema multiforme due to Cotrimoxazole

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage7.png
Figure 8

Acneiform eruptions due to ATT drugs

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage8.png
Figure 9

vasculitis due to an unknown drug

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage9.png
Figure 10

Nevirapine induced TEN

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/066a3cb8-854f-4052-8eff-70ce572f989cimage10.png

Discussion

Adverse drug reactions forms an important and common problem in both inpatient and outpatient setting. Occurrence of these ADRs is one of the commonest causes for poor adherence to treatment. Knowledge of these drug eruptions, the causative agents and the prognostic indicators are essential for the clinician for better management of these cases and to avoid them for future use.

Females outnumbered males in our study with male to female ratio of 0.83:1. This is in accordance with the study done by Emmanuel et al 8 but not with a study done by Anshu Kumar Jha. 9 Most of the studies reported in the literature show a higher number of females as seen in our study. Although not entirely clear, these differences have been attributed to gender related differences in pharmacokinetic, immunological and hormonal factors. 10

Majority of the patients were middle aged (31 to 40 years). Youngest patient was 18years old and oldest patient was 67 years old. This finding is in accordance with the study done by Padukadan et al 11 and Emmanuel et al where in the mean age group was 41+/- 11.36 years. 8 This could be because of the fact that HIV is more prevalent in the adult population.

The most common CADR was maculopapular eruption followed by FDE. This is in concordance with studies done by SA Coopman et al and Gail Todd et al 12, 13 where in the most common presentation was maculopapular rash followed by EM and urticaria in HIV patients. 12

The common presentation of CADRs was also maculopapular rash followed by urticaria and FDE in general population as seen in studies done by Thakkar et al and Modi et al 14, 15 where as it was angioedema and urticaria followed by maculopapular rash in a study done by Akpinar et al. 16

The most common drug implicated was ART followed by antibiotics in our study, this could be because of the fact that patients tend to consult the physician soon after an ADR to ART as they have to take these medications lifelong. Patients tend to stop other drugs which are given for milder ailments on their own and less likely to seek medical help. This is in accordance with the study done by Mayur Popat Pawar et al where in the most common drug implicated was antiretroviral drugs (75.56%) followed by antimicrobials, antiepileptics and NSAIDs.17

In our study majority had a probable causality followed by possible causality and definite causality according to Naranjo scoring system which is in concordance with a study done by Anshu Kumar Jha et al where in they had a probable causality of 66.04% and a possible causality of 33.96%.9 This causality association is done in order to determine whether drug discontinuation is mandatory, as well as to put emphasis on patient education in order to avoid the development of ADRs in the future.

In our study, majority of the patients had mild followed by moderate and severe drug reaction. It is in accordance with other studies.18, 19

The most common laboratory derangement was increase in liver enzyme levels followed by eosinophilia, increased bilirubin and raised serum creatinine. This finding is in accordance with the study done by Colafigli et al, where increased liver enzymes were seen in 22.3%.20 Liver is known to be affected in various ADRs as the drug metabolism tends to occur here. Some drugs are directly injurious and others are transformed by the liver into chemicals that can cause injury. There are three types of liver toxicity; dose dependent toxicity, idiosyncratic toxicity and drug allergy. Renal is also affected in ADRs as this is the main route of drug excretion.

There was significant association between raised liver enzymes and raised serum creatinine with SJS in our study. In a study done by Aroni Chatterjee el al, where in they studied SJS patients with HIV, they found that there was increase in mean BUN and serum creatinine in 67% and raised liver enzymes in 38%.21

We had only one patient with TEN to Nevirapine. She had raised liver enzymes, raised serum creatinine and BUN, low Na+ and high K+ levels. In a study done by Aroni Chatterjee el al, where in they studied TEN patients with HIV, they found that there was increase in mean BUN and serum creatinine in 54% and liver enzymes raised in 47%.21

There was significant association between increased liver enzymes, total bilirubin, Eosinophilia and raised Serum creatinine with DRESS. Liver is one of the commonly involved internal organs in DRESS, as there will be detoxification defect leading to reactive metabolite formation and immunological reaction. Eosinophilia is also common because inflammatory cascade may be induced by interleukin 5 release from drug specific T cells.

We didn’t find any significant association between deranged laboratory parameters and Maculopapular eruption, EM, urticaria, angioedema, FDE, Acneiform, Pruritis, Vasculitis, lichenoid, or photosensitive drug rash.

Conclusion

Though the global mortality from HIV has significantly declined due to highly active antiretroviral therapy, there has been a concurrent increase in the incidence of cutaneous drug reactions. With increasing recognition of variety of clinical manifestations of CADRs with anti-retroviral and other drugs, elucidation of underlying cellular and molecular mechanisms and identification of high risk people are needed. Timely identification of these ADRs, stopping of the offending drug and prompt treatment at the earliest is advised as these severe cutaneous ADRs are associated with internal organ damage.

Source of Funding

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

J Borras-Blasco A Navarro-Ruiz C Borras E Castera Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infectionJ Antimicrob Chemother200862587991010.1093/jac/dkn292

2 

A Lowell Goldsmith Stephen I katz 8th Edn. Fitzpatrick’s Dermatology in General MedicineCutaneous manifestation of hiv disease, chapter198/Viral & Reckettsial disease Section224467

3 

Christopher E.M. Griffiths Jonathan B T Bleiker Bleiker Rook’s Textbook of DermatologyHIV and the Skin/Drug reaction19th Edn.9014

4 

J S Dover R A Johnson Cutaneous manifestations of human immunodeficiency virus infectionArch Dermatol199112715495810.1111/bjd.15623

5 

D R Veena Cuckoo Aiyappa H V Anuradha T K Sumathy Study on cutaneous adverse drug reactions: clinical pattern and causative agentsJ Pharmaceu Res201110115

6 

A Kumar L Majhee M Gari Causality, severity and preventability assessment of adverse drug reactions in patients received anti-retroviral therapy in a tertiary care hospital: A retrospective studyNational J Physiol, Pharm Pharmacol2017721788210.5455/njppp.2017.7.0821922082016

7 

S Panda Causality or Relatedness assessment in adverse drug reaction and its relevance in dermatologyIndian J Dermatol2018631821

8 

E A Kouotou J R Nansseu V N Ngono S A Tatah A C Zoung-Kanyi Bissek E C N Ndam Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, CameroonDermatol Res Pract201720171610.1155/2017/6216193

9 

A K Shenoy M N Chowta A Gadgade A K Jha J T Ramapuram Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospitalPerspect Clin Res20156134810.4103/2229-3485.148808

10 

M Rademaker Do Women Have More Adverse Drug Reactions?Am J Clin Dermatol2001263495110.2165/00128071-200102060-00001

11 

D Padukadan D M Thappa Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care centre in South IndiaIndian J Dermatol Venerol Leprol200470204

12 

G Todd Adverse Cutaneous Drug Eruptions and HIV: a Clinician's Global PerspectiveDermatol Clin20062444597210.1016/j.det.2006.06.008

13 

S A Coopman R A Johnson R Platt R S Stern Cutaneous Disease and Drug Reactions in HIV InfectionN Engl J Med1993328231670410.1056/nejm199306103282304

14 

S Thakkar T K Patel R Vahora P Bhabhor R Patel Cutaneous adverse drug reactions in a tertiary care teaching hospital in India: An intensive monitoring studyIndian J Dermatol20176266182510.4103/ijd.ijd_703_16

15 

A Modi M Desai S Shah B Shah Analysis of cutaneous adverse drug reactions reported at the regional ADR monitoring centerIndian J Dermatol201964325010.4103/ijd.ijd_682_16

16 

F Akpinar E Dervis Drug eruptions: An 8-year study including 106 inpatients at a dermatology clinic in TurkeyIndian J Dermatol2012573194810.4103/0019-5154.96191

17 

M P Pawar S M Pore S N Pradhan Nevirapine Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care HospitalJ Clin Diagn Res20159111720

18 

N S Shah S P Chauhan M K Desai A Shah A safety analysis of different drug regimens used in human immunodeficiency virus-positive patientsIndian J Sex Transm Dis AIDS2018392849010.4103/ijstd.ijstd_116_17

19 

S Mukherjee N Era B Saha S K Tripathi Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern IndiaIndian J Pharmacol2017493223810.4103/ijp.ijp_304_16

20 

M Colafigli S Di Giambenedetto L Bracciale I Fanti M Prosperi R Cauda Long-term follow-up of nevirapine-treated patients in a single-centre cohortHIV Med2009108461910.1111/j.1468-1293.2009.00713.x

21 

A Chatterjee I Thakur S Ansari R P Chatterjee R Sarkar S K Guha A Comparative Insight into the Incidence of Steven Johnson Syndrome/ Toxic Epidermal Necrolyis among the Immunocompromized Patient Populace of Eastern India with a Distinctive Emphasis on the Possible Association of Human CytomegalovirusJ AIDS Clin Res2017080670610.4172/2155-6113.1000706



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2020.073


Article Metrics






Article Access statistics

Viewed: 1808

PDF Downloaded: 628



Medical Abbreviation List